|Bid||0.0000 x 800|
|Ask||0.0000 x 1800|
|Day's Range||1.5200 - 1.6300|
|52 Week Range||1.2800 - 5.7700|
|Beta (5Y Monthly)||1.20|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), announces that it has filed amended and restated audited financial statements (the "Amended and Restated Financials") for the financial year ended March 31, 2022, which amend and restate the previously filed audited financial statements for the financial year ended March 31, 2022 (the "Financial Statements").
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces the commencement of a 4-year, $1.6M research project in collaboration with Professors Mohini Sain and Ning Yan from the University of Toronto ("U of T") and Ford Powertrain Engineering Research and Development Centre ("PERDC"). Funding for the project includes $1.2M from the Mitacs Accelerate program. Prof.
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property ("IP") development and commercialization company, is pleased to announce that it was chosen to present the Company's ZenGUARD™ technology at the 12th Annual Global Summit on Regulatory Science on October 19-21, 2022, in the Innovative Nanotechnology Advancement in the Drug and Medical Device track.